Isolation, Structure Elucidation and Biological Evaluation of Lomaiviticins F–H, Dimeric Benzofluorene Glycosides from Marine-Derived Micromonospora sp. Bacterium
Marine Drugs · 2025
DOI: 10.3390/md23020065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Fan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, School of Ph…. Hauptthemen laut MEDLINE: Micromonospora, Glycosides, Fluorenes, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China,, NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
The discovery of new natural products remains a cornerstone of therapeutic innovation, and effective analytical tools for rapid dereplication can significantly accelerate this process. Using Isotopic Fine Structure (IFS) mass spectrometry, we rapidly identified three new dimeric benzofluorene glycosides, lomaiviticins F–H (1–3), from a marine-derived Micromonospora sp. bacterium. These compounds were isolated and structurally elucidated through advanced spectroscopic techniques, including FT-ICR-MS and NMR. Lomaiviticins F–H exhibit unique structural features, notably the 4-O-methyl-l-angolosamine moieties, which differentiate them from previously known lomaiviticins A–E. The discovery of these compounds highlights distinct biosynthetic linkages within the lomaiviticin family, particularly the C2–C2′ conjoining bonds characteristic of the dimers. Compounds 1–3 were evaluated for in vitro cytotoxicity against a panel of human cancer cell lines; the resulting IC50 values confirmed that the dimeric diazofluorenes of lomaiviticins A and B are critical for anticancer activity. These findings emphasize the utility of IFS in expediting natural product discovery while providing valuable insights into structural and functional characterizations of bioactive compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, School of Pharmaceutical Sciences, Key Laboratory of Combinatorial Biosynthesis an…
- Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI 53705, USA.
- Small Molecule Screening & Synthesis Facility, UW Carbone Cancer Center, Madison, WI 53705, USA.
- Department of Medicinal Chemistry, University of Utah, 30 South 2000 East, Salt Lake City, UT 84112, USA.
ORCID-Profile: Fan Zhang, Scott R Rajski, Tim S Bugni
Förderung
- National Natural Science Foundation of China, National Key Research and Development Program of China,
- NIGMS NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- NIH
- National Magnetic Resonance Facility at Madison (NMRFAM)
Zitieren
APA
Zhang, F., Wang, W., Braun, D. R., Ananiev, G. E., Liao, W., Harper, M. K., Rajski, S. R., & Bugni, T. S. (2025). Isolation, Structure Elucidation and Biological Evaluation of Lomaiviticins F–H, Dimeric Benzofluorene Glycosides from Marine-Derived Micromonospora sp. Bacterium. Marine Drugs. https://doi.org/10.3390/md23020065
Vancouver
Zhang F, Wang W, Braun DR, Ananiev GE, Liao W, Harper MK, et al. Isolation, Structure Elucidation and Biological Evaluation of Lomaiviticins F–H, Dimeric Benzofluorene Glycosides from Marine-Derived Micromonospora sp. Bacterium. Marine Drugs. 2025. doi:10.3390/md23020065
BibTeX
@article{Zhang2025,
author = {Zhang, Fan and Wang, Wenhui and Braun, Doug R and Ananiev, Gene E and Liao, Weiting and Harper, Mary Kay and Rajski, Scott R and Bugni, Tim S},
title = {Isolation, Structure Elucidation and Biological Evaluation of Lomaiviticins F–H, Dimeric Benzofluorene Glycosides from Marine-Derived Micromonospora sp. Bacterium},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23020065}
}
EUVIMED